Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
US10377768B2 · kind B2 · utility
5Cited by
30References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 5, 2017 |
| Grant date | Aug 13, 2019 |
| Priority date | — |
| Expiry date | May 5, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides tetrahydronaphthyridine and related compounds, pharmaceutical compositions, methods of inhibiting RORγ activity, reducing the amount of IL-17 in a subject, and treating immune disorders and inflammatory disorders using such tetrahydronaphthyridine and related compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.